[1]
A. Piasecki, M. Sitnik, J. Olszewski, M. Bara, K. Herjan, and P. Armański, “The changing landscape of mineralocorticoid receptor antagonists – finerenone in cardiovascular and renal health”, Prospect. Pharm. Sci., vol. 22, no. 1, pp. 11–15, Feb. 2024.